TherapeuticsMD, Inc.
Symbol: TXMD (NASDAQ)
0.00
▼ (-100.00%) -1.220
Company Description:
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.22
- Yesterday High: $1.23
- Yesterday Low: $1.15
- Yesterday Volume: 107.91K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: TherapeuticsMD, Inc.
- Website: https://www.therapeuticsmd.com
- Listed Date: 2002-01-28
- Location: BOCA RATON, FL
- Market Status: Active
- CIK Number: 0000025743
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $13.54M
- Round Lot: 100
- Outstanding Shares: 11.57M
- Asset Type: CS
RECENT FILINGS FOR TXMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-30 | 10-K/A | View |
| 2025-04-15 | 4 | View |
| 2025-04-15 | 4 | View |
| 2025-04-10 | 4 | View |
| 2025-04-09 | 8-K | View |
| 2025-03-27 | 10-K | View |
| 2025-03-27 | 8-K | View |
| 2025-02-20 | 4 | View |
| 2025-02-20 | 4 | View |
| 2025-02-20 | 4 | View |
| 2025-02-20 | 4 | View |
| 2025-02-12 | SCHEDULE 13G | View |
| 2024-12-05 | 8-K | View |
| 2024-11-12 | SC 13G | View |
| 2024-11-12 | 10-Q | View |
| 2024-11-12 | 8-K | View |
Latest News on TXMD